Fresenius Medical Care

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$4,766,438
$4,725,000
$4,988,000
$4,936,237
Gross Profit
1,166,489
1,174,000
1,350,000
1,228,997
EBITDA
736,457
729,000
880,446
803,400
EBIT
352,695
341,265
478,016
410,762
Net Income
187,000
70,959
187,925
84,351
Net Change In Cash
4,766,438
4,725,000
4,988,000
4,936,237
Free Cash Flow
277,236
-6,592
468,788
622,976
Cash
1,090,214
1,148,000
1,403,492
1,553,253
Basic Shares
293,413
586,826
293,413
293,413

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$19,454,000
$19,398,000
$17,619,000
$17,859,000
Gross Profit
4,925,000
5,310,000
5,077,000
5,537,000
EBITDA
3,438,617
1,580,000
1,925,000
2,315,000
EBIT
1,825,881
-140,135
339,633
728,131
Net Income
498,997
673,405
969,308
1,164,377
Net Change In Cash
19,454,000
19,398,000
17,619,000
17,859,000
Free Cash Flow
1,944,205
756,000
806,000
2,145,000
Cash
1,403,492
1,273,787
1,481,655
1,081,539
Basic Shares
293,413
293,246
293,065
294,278

Earnings Calls

Quarter EPS
2024-06-30
$0.24
2024-03-31
$0.41
2023-12-31
$0.44
2023-09-30
$0.28